Manulife (Manufacturers Life Insurance)’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
Other funds holding OSIR
AAM
GF
CCM
WIC
BCM
Manulife (Manufacturers Life Insurance)'s OSIR Position: Q1 2019 in Review
Manulife (Manufacturers Life Insurance) sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2019, closing a stake of 130,077 shares — an estimated $1.76M sold.
Manulife (Manufacturers Life Insurance) first reported a position in OSIR in Q2 2013 and held it in 17 quarters. The position peaked at $7.12M in Q3 2018. 57 funds tracked by Wall St. Rank hold OSIR as of Q1 2019.
- Manulife (Manufacturers Life Insurance) reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 130,077 Osiris Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $1.76M.
- Manulife (Manufacturers Life Insurance) first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 17 quarters.
- Manulife (Manufacturers Life Insurance)'s Osiris Therapeutics, Inc. Common Stock position peaked at $7.12M in Q3 2018.
- 57 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2019.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2019, filed 13 May 2019.